drugset / Trial / NCT02535000

Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery

NCT02535000

Phase 4 Completed 60 enrolled Serviço de Anestesiologia de Joinville
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Duloxetine as an analgesic agent in patients undergoing elective spine surgery: evaluation with fentanyl demand controlled by the patient. The primary objective is to evaluate the efficacy of duloxetine in fentanyl consumption during the postoperative period of patients undergoing elective spine surgery by intervertebral disc degeneration . Secondary endpoints were pain scores and the presence or absence of adverse effects such as headache, nausea, vomiting, itching, dizziness and drowsiness.

Timeline

Start
2014-01-01
Primary completion
2015-10-20
Completion
2015-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 60 mg Oral